Chronic venous insufficiency (CVI) is one of those health conditions that quietly affects millions, yet many people don’t ...

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

Strategic investment follows a transformative year marked by the national launch of the AVENTUS thrombectomy system.

CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that ...

The Central Bank of Egypt (CBE) has approved a package of procedures that aims to facilitate foreign exchange trading for import and export, several banking sources told Ahram Online. These procedures ...

CorMedix announces preliminary, unaudited financial results for Q4 and FY 2025, including net revenue of approximately $127 million and $310 million, for Q4 2025 and FY 2025, respectively, FY 2025 Pro ...